Menu
Back to Journals » Psoriasis: Targets and Therapy » Volume 10
Psoriasis: Targets and Therapy
ISSN: 2230-326X
- View all (136)
- Volume 14, 2024 (3)
- Volume 13, 2023 (7)
- Volume 12, 2022 (22)
- Volume 11, 2021 (14)
- Volume 10, 2020 (8)
- Volume 9, 2019 (13)
- Volume 8, 2018 (12)
- Volume 7, 2017 (9)
- Volume 6, 2016 (15)
- Volume 5, 2015 (13)
- Volume 4, 2014 (5)
- Volume 3, 2013 (4)
- Volume 2, 2012 (10)
- Volume 1, 2011 (1)
Archive: Volume 10, 2020
A Successful Treatment of Ostraceous Psoriasis Associated with Psoriatic Arthritis in Children: A Case Report
Rowawi R, Dwipangestu G, Suwarsa O, Dharmadji HP, Sutedja E, Pangastuti M, Gunawan H
Psoriasis: Targets and Therapy 2020, 10:61-66
Published Date: 30 December 2020
CMV Infection: A Clinical Challenge in Biological Therapy? The Case of Asymptomatic Patients with Persistent Positive Immunoglobulin M Anti-CMV Treated with Secukinumab
Gambardella A, Licata G, Calabrese G, De Rosa A, Pagliuca F, Alfano R, Argenziano G
Psoriasis: Targets and Therapy 2020, 10:57-60
Published Date: 27 November 2020
Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
Mahé E
Psoriasis: Targets and Therapy 2020, 10:45-56
Published Date: 27 November 2020
Correlation Between Psoriasis Severity and Nonalcoholic Fatty Liver Disease Degree Measured Using Controlled Attenuation Parameter
Gandha N, Wibawa LP, Jacoeb TNA, Sulaiman AS
Psoriasis: Targets and Therapy 2020, 10:39-44
Published Date: 20 October 2020
The Skin May Clear But the Arthritis Won’t Disappear: Focusing on Concomitant and New-Onset Psoriatic Arthritis in a Daily Practice Cohort of Psoriasis Patients on Biologic Therapy
van Muijen ME, van Hal TW, Groenewoud HMM, van den Reek JMPA, de Jong EMGJ
Psoriasis: Targets and Therapy 2020, 10:29-37
Published Date: 5 October 2020
The Unmet Need for Clinical Guidelines on the Management of Patients with Plaque Psoriasis in Africa and the Middle East
Steinhoff M, Ammoury AF, Ahmed HM, Gamal MFS, El Sayed MH
Psoriasis: Targets and Therapy 2020, 10:23-28
Published Date: 20 August 2020
Circulating Cell-Free DNA as Inflammatory Marker in Egyptian Psoriasis Patients
Anani HAA, Tawfeik AM, Maklad SS, Kamel AM, El-Said EE, Farag AS
Psoriasis: Targets and Therapy 2020, 10:13-21
Published Date: 21 May 2020
Dimethyl Fumarate Targets MSK1, RSK1, 2 and IKKα/β Kinases and Regulates NF-κB /p65 Activation in Psoriasis: A Demonstration of the Effect on Peripheral Blood Mononuclear Cells, Drawn from Two Patients with Severe Psoriasis Before and After Treatment with Dimethyl Fumarate
Gesser B, Rasmussen MK, Iversen L
Psoriasis: Targets and Therapy 2020, 10:1-11
Published Date: 31 March 2020